A research team led by CiRA Professor Haruhisa Inoue has developed a cellular dissection of polygenicity (CDiP) technology, which enables the reconstruction of the clinical conditions of Alzheimer’s disease (AD) from patients’ genetic data by using iPS cells and artificial intelligence.
Dissection of the polygenic architecture using iPSC lines derived from Alzheimer’s disease
A research team led by CiRA Professor Haruhisa Inoue has developed a cellular dissection of polygenicity (CDiP) technology, which enables the reconstruction of the clinical conditions of Alzheimer's disease (AD) from patients' genetic data by using iPS cells and artificial intelligence.